Society of Gynecologic Oncology

Name

Society of Gynecologic Oncology

Legal name

Society of Gynecologic Oncology

Website

https://sgo.org

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: SGO generates revenue through annual membership dues from over 2,700 members including gynecologic oncologists, medical oncologists, physician assistants, nurse practitioners, and patient advocates. Various membership tiers exist including full members, international members, allied health professionals, and students.
2. Meetings and Events: Revenue from annual and winter meetings, conferences, webinars, and educational events including registration fees, exhibitor sponsorships, and continuing education credits.
3. Corporate Partnerships and Sponsorships: Partnerships with pharmaceutical companies including AstraZeneca, Corcept, Daiichi Sankyo, Eisai, Gilead, GSK, AbbVie, Karyopharm, Merck, Natera, and Pfizer/Genmab for exhibition, sponsorship, and corporate partnership programs.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

SGO is a 501(c)(3) nonprofit professional medical society that provides education, scientific meetings, peer-reviewed journals, career services, and advocacy to gynecologic oncologists, advanced practice providers, and allied health professionals. It sells individual and institutional memberships, registrations for in-person and virtual meetings, eLearning course access, and journal subscriptions, and operates the Foundation for Women's Cancer as a patient-education and fundraising subsidiary.

Product overview

The Society of Gynecologic Oncology operates as a professional membership organization offering a comprehensive portfolio of products and services for the gynecologic oncology community. The organization's core offerings include annual and specialized conferences (Annual Meeting on Women's Cancer, Winter Meeting, Allied Health Professionals Meeting, MIS Course), online learning platforms (ConnectEd eLearning, MySGO online community), peer-reviewed publications (Gynecologic Oncology journal, Gynecologic Oncology Reports), and career development resources (Career Center, Coding Fellowship). SGO also supports research through the BRIDGES 2.0 Research Initiative, fosters leadership diversity via the LEAD Program, and advances advocacy through Congressional engagement. The affiliated Foundation for Women's Cancer extends patient education and fundraising capabilities. This multi-channel approach combines in-person events, digital platforms, research programs, and member services to support the gynecologic oncology profession across education, networking, research, and advocacy.

Differentiator

Problem solved

Functional benefit

Brands

• Foundation for Women's Cancer: Official foundation of SGO dedicated to outreach, education, and fundraising arm of SGO for gynecologic cancer awareness and research

Products and services

• Annual Meeting on Women's Cancer

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

19 partnerships are on record, tiered core, major and minor.

• Foundation for Women's Cancer (FWC)coreStrategic or Co-development PartnerThe Foundation for Women's Cancer is the official foundation of SGO, dedicated to outreach, education, and is the fundraising arm of SGO. The missions are tied together - FWC fuels what SGO does, and what SGO does powers FWC. FWC provides patient education, survivor support, advocacy, and raises money to support SGO's work.
• GOG Foundation, Inc.coreStrategic or Co-development PartnerSynergistic partnership announced to advance the missions of all three organizations. The GOG Foundation is a clinical trials research organization focused on gynecologic oncology, working collaboratively with SGO on research initiatives including the BRIDGES 2.0 Research Initiative.
• AstraZenecamajorGTM or Marketing PartnerCorporate partner displayed on SGO website. AstraZeneca is a major pharmaceutical company in the oncology space with products relevant to gynecologic cancers.
• Corcept TherapeuticsmajorGTM or Marketing PartnerCorporate partner displayed on SGO website. Corcept is a pharmaceutical company focused on oncology therapeutics.
• Daiichi SankyomajorGTM or Marketing PartnerCorporate partner displayed on SGO website. Daiichi Sankyo is a global pharmaceutical company with oncology pipeline.
• EisaimajorGTM or Marketing PartnerCorporate partner displayed on SGO website. Eisai is a pharmaceutical company with oncology focus including Lenvima for endometrial cancer.
• Gilead SciencesmajorGTM or Marketing PartnerCorporate partner displayed on SGO website. Gilead is a biopharmaceutical company with oncology therapeutics.
• GSKmajorGTM or Marketing PartnerCorporate partner displayed on SGO website. GSK is a global healthcare company with oncology focus.
• AbbViemajorGTM or Marketing PartnerCorporate partner displayed on SGO website. AbbVie is a major pharmaceutical company with oncology portfolio.
• Karyopharm TherapeuticsmajorGTM or Marketing PartnerCorporate partner displayed on SGO website. Karyopharm is focused on novel oncology therapeutics.
• MerckmajorGTM or Marketing PartnerCorporate partner displayed on SGO website. Merck is a major pharmaceutical company with Keytruda and other oncology products relevant to gynecologic cancers.
• NateramajorGTM or Marketing PartnerCorporate partner displayed on SGO website. Natera focuses on cell-free DNA testing and molecular diagnostics.
• Pfizer/GenmabmajorGTM or Marketing PartnerCorporate partner displayed on SGO website. Pfizer/Genmab collaboration focuses on oncology therapeutics including Tivdak for cervical cancer.
• CRD AssociatesminorGTM or Marketing PartnerSGO's government relations team providing advocacy representation and legislative affairs support.
• ACOG (American College of Obstetricians and Gynecologists)majorStrategic or Co-development PartnerJoint statements and collaborative work on practice guidelines including cervical cancer screening recommendations and contraception guidance for cancer patients.
• ACCC (Association of Community Cancer Centers)majorStrategic or Co-development PartnerJoint education collaborative and ovarian cancer initiative between SGO and ACCC for advancing cancer care education.
• Society of Family PlanningminorStrategic or Co-development PartnerCollaborative release of updated clinical guidance on contraception for individuals affected by cancer.
• ASTRO (American Society for Radiation Oncology)minorStrategic or Co-development PartnerCollaborative clinical practice guidelines including ASTRO's radiation therapy for cervical cancer guidelines with SGO input.
• NRG OncologycoreStrategic or Co-development PartnerNRG Oncology is a National Cancer Institute-funded research organization focused on gynecologic, breast, and gastrointestinal cancers. SGO members participate in NRG clinical trials.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Association of Community Cancer Centers (ACCC): ACCC is an oncology multidisciplinary organization whose members deliver cancer care in community settings. SGO and ACCC run a joint ovarian cancer education collaborative and partially overlap on continuing education for oncologists and allied health professionals.

Broad incumbents

• American Association for Cancer Research (AACR): AACR is the large cancer-research society publishing multiple journals and running an annual meeting that draws gynecologic oncology research. SGO members present and publish in both venues, putting AACR in partial competition for sponsor dollars and research submissions.
• American Society for Radiation Oncology (ASTRO): ASTRO is the radiation oncology professional society that co-authors gynecologic cancer guidelines with SGO (e.g., cervical cancer radiation guidelines). Same membership-meeting-sponsorship model and shared committee work make it a structural peer.
• American College of Obstetricians and Gynecologists (ACOG): ACOG is a much larger ob/gyn society that overlaps on women's health guidelines, cervical cancer screening, and contraception guidance for cancer patients (SGO already partners with ACOG on joint statements). Comparable business model but wider women's-health scope rather than oncology specialty.

Direct peers

• American Society of Clinical Oncology (ASCO): ASCO is the largest U.S. professional society for oncologists with similar membership-dues + meeting + journal + pharma sponsorship model. SGO members also frequently hold ASCO memberships for general oncology education, making ASCO the closest like-for-like structural peer in business model and revenue mix.
• International Gynecologic Cancer Society (IGCS): IGCS is the global multidisciplinary society specifically for gynecologic oncology research and education. It directly overlaps SGO's physician audience, runs an annual meeting, and competes for the same members and corporate sponsors in gynecologic oncology.
• Society of Surgical Oncology (SSO): SSO is a surgical-oncology professional society with membership dues, an annual meeting, and similar committee-driven governance. Many SGO members also belong to SSO, and the two compete for surgical CME dollars and industry sponsorship.

Regional players

• European Society of Gynaecological Oncology (ESGO): ESGO is the European counterpart to SGO, focused on the same gynecologic oncology subspecialty with congresses, guidelines, and training. Comparable on specialty and activities but primarily serves European members rather than competing directly in the U.S.

Others

• NRG Oncology: NRG Oncology is the NCI-funded clinical trials cooperative for gynecologic, breast, and GI cancers. SGO members participate in NRG trials and the organizations collaborate on research, making NRG an adjacent ecosystem partner rather than a competitor.
• GOG Foundation: The GOG Foundation runs gynecologic oncology clinical trials and partners with SGO on the BRIDGES 2.0 Research Initiative. Same physician-audience overlap but a research/operations focus rather than a membership society.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sgo_org
• YouTubeyoutube.com/user/sgynecologiconcology
• Facebookfacebook.com/SGO.org
• LinkedInlinkedin.com/company/sgo
• Instagraminstagram.com/sgo_org

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Society of Gynecologic Oncology